These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity. Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica. Krauledat PB; Krapf FE; Manger B; Kalden JR Rheumatol Int; 1985; 5(3):97-101. PubMed ID: 3892637 [TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)]. Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016 [TBL] [Abstract][Full Text] [Related]
5. [Absence of circulating immune complexes and of serum anti-IgG antibodies during ankylosing spondylarthritis]. Duquesnoy B; Santoro F; Delcambre B; Wattre P Rev Rhum Mal Osteoartic; 1979 Jun; 46(6):397-401. PubMed ID: 315612 [TBL] [Abstract][Full Text] [Related]
6. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis. Duquesnoy B; Santoro F; Wattre P; Delcambre B Ann Rheum Dis; 1980 Oct; 39(5):449-52. PubMed ID: 6969066 [TBL] [Abstract][Full Text] [Related]
7. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196 [TBL] [Abstract][Full Text] [Related]
8. The absence of circulating immune complexes in patients with ankylosing spondylitis. Maksymowych W; Dasgupta MK; Rothwell RS; Dossetor JB; Russell AS Rheumatol Int; 1981; 1(3):107-9. PubMed ID: 6981182 [TBL] [Abstract][Full Text] [Related]
9. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates. Fletcher DS; Lin TY J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441 [TBL] [Abstract][Full Text] [Related]
10. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. Kinsella TD; Espinoza L; Vasey FB J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743 [TBL] [Abstract][Full Text] [Related]
17. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848 [TBL] [Abstract][Full Text] [Related]
18. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor. Gabriel A; Agnello V J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292 [TBL] [Abstract][Full Text] [Related]
19. Breakdown products of C 3 in human synovial fluids. Zvaifler NJ J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of two methods for detection of circulating immune complexes in patients with rheumatoid arthritis. Sølling J; Sølling K; Lassen L Scand J Rheumatol; 1980; 9(2):118-22. PubMed ID: 7001616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]